Burleson & Co’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-107
| Closed | -$32K | – | 376 |
|
|
2021
Q1 | $32K | Sell |
107
-7,075
| -99% | -$2.12M | 0.01% | 205 |
|
|
2020
Q4 | $1.83M | Buy |
7,182
+993
| +16% | +$253K | 0.32% | 55 |
|
|
2020
Q3 | $1.62M | Buy |
6,189
+1,400
| +29% | +$366K | 0.31% | 61 |
|
|
2020
Q2 | $1.57M | Buy |
4,789
+1,500
| +46% | +$492K | 0.34% | 58 |
|
|
2020
Q1 | $1.03M | Buy |
3,289
+1,529
| +87% | +$477K | 0.27% | 72 |
|
|
2019
Q4 | $584K | Sell |
1,760
-232
| -12% | -$77K | 0.16% | 93 |
|
|
2019
Q3 | $501K | Buy |
1,992
+1,107
| +125% | +$278K | 0.17% | 81 |
|
|
2019
Q2 | $414K | Buy |
885
+193
| +28% | +$90.3K | 0.17% | 78 |
|
|
2019
Q1 | $334K | Buy |
692
+219
| +46% | +$106K | 0.14% | 86 |
|
|
2018
Q4 | $286K | Buy |
473
+33
| +8% | +$20K | 0.15% | 86 |
|
|
2018
Q3 | $251K | Buy |
+440
| New | +$251K | 0.14% | 90 |
|